Pharmaceutical Technology, August 2022

Mitigating the Risk from Excipient Variability

August 03, 2022

Special Report

46

8

This article reviews sources of excipient variability, including raw materials and processing, both of which may vary from supplier to supplier and from plant to plant for a single manufacturer.

Vaccine Administration: The Growing Role of Prefilled Syringes

August 03, 2022

Manufacturing

46

8

The option of using prefilled syringes for vaccinations is not (yet) available for all types of vaccines. Stakeholders are working to expand that option while also pursuing other non-traditional routes of administration.

FDA Joins Effort to Curb Drug Patent Abuses

August 02, 2022

Regulatory Watch

46

8

FDA and the USPTO hope to promote competition by challenging strategies designed to block timely approval of generics and biosimilars.

Navigating the Future

August 02, 2022

From The Editor

46

8

Promising applications for targeted delivery may be cresting the horizon.

New Guidance on the Use of Real-World Evidence

August 02, 2022

Regulatory Watch

46

8

Pharma’s leveraging real-world evidence to drive product approval, reimbursement, and market access.

Regulatory Applications for Biologics

August 02, 2022

Ask the Expert

46

8

Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, answers some commonly asked questions about biologics license applications.

Demerger and the Future

August 02, 2022

From The Editor

46

8

GSK has completed its demerger of Haleon and has signed an agreement to help support future pandemic preparedness in Europe.

The Stick and Carrot of Quality Management

August 02, 2022

From the CEO

46

8

How can we fix the quality manufacturing issues that come with product shortages?